TERUMO CORPORATION - KOFU SURFLO WINGED INFUSION SET; SET, ADMINISTRATION, INTRAVASCULAR
|
Back to Search Results |
|
Catalog Number 1SV*23BLS |
Device Problem
Patient-Device Incompatibility (2682)
|
Patient Problems
Edema (1820); Skin Inflammation (2443)
|
Event Date 03/03/2016 |
Event Type
malfunction
|
Manufacturer Narrative
|
Udi - not required until 09/2016.The actual device was not returned to the manufacturing facility for evaluation.Therefore the investigation results are based upon the user facility information and the evaluation of the retention samples from the reported product code/lot# combination.Visual inspection revealed no defects.The following series of biocompatibility tests have be conducted in accordance with iso (b)(4): intradermal reaction, acute toxicity, heat buildup, hemolytic, cytotoxicity and sensitizing property meeting specification.A review of the manufacturing and inspection records was conducted with no relevant findings.There is no evidence that this event was related to a device defect or malfunction and the exact cause cannot be determined.(b)(4).All available information has been placed on file in quality assurance for tracking, trending, and follow up.Device not returned to manufacturer.
|
|
Event Description
|
The user facility reported that three patients out of fifteen had reactions such as edema, redness and heat when using the surflo winged infusion set used for subcutaneous administration of morphine.Follow up communication with the user facility on (b)(6) 2016 reported: some of those patients who required palliative care passed away since these incidents.Additional information was reported on regarding patient #2: on (b)(6) 11h05m redness and slight edema on the site, as per the patient: demangeaison since the first subcutaneous injection through the winged set, changed the winged set.(b)(6) 23h00, pain, induration, heat, slight redness and demangeaison at the site of the winged set, removal of the winged infusion set.The patient was diagnosed with lung cancer with hepatic metastases and has had on-going palliative chemotherapy.Context of palliative care.Following the event on (b)(6), the doctor had been notified about the reaction to the subcutaneous winged set.It was reported that the patient could undertake per order sheet between doses or could try injection via an iv catheter or train the caregiver on direct subcutaneous injections.(b)(6) 23h00 recommendation to take statex per order sheet and advise if not relieved.The user facility reported similar events for other devices with the same product code/lot# combination, see mdr's 9681835-2016-00010, 968185-2016-00012 and 9681835-2016-00016.
|
|
Manufacturer Narrative
|
This report is being submitted as follow-up # 1 to provide the evaluation results of the eight returned unused samples.The actual device was not returned to the manufacturing facility, however eight unused samples of the reported product/lot number combination was returned for evaluation.Microscopic inspection of the needle of the returned eight unused samples revealed no defects.
|
|
Search Alerts/Recalls
|
|
|